CutisPharma names Steven Dinh as chief scientific officer
Mr. Dinh brings to CutisPharma over 35 years of industry experience. Most recently, he served as Vice President and Chief Scientific Officer of Noven Pharmaceuticals, where he headed the company’s Science and Technology organization.
He also held leadership roles of increasing responsibility at E.I. Dupont de Nemours & Co., Ciba-Geigy (Novartis), Emisphere Technologies and Noven Pharmaceuticals.
Mr. Dinh received his Doctor of Science in chemical engineering from the Massachusetts Institute of Technology and a Master's degree in chemical engineering from Cornell University.
He is a Fellow of the American Association of Pharmaceutical Scientists as well as the American Institute for Medical and Biological Engineering. ■
LATEST MOVES FROM Massachusetts
- Dunkin' Brands Group CFO Paul Carbone to leave
- Abpro appoints Gavin MacBeath as CSO
- bluebird bio appoints two executives
- Biogen appoints Anirvan Ghosh as SVP
- Brightcove adds Diane Hessan to board
More inside POST
PostNL Q4 revenue €955 million Earnings